I Ranked 10 Beaten-Down Stocks — Only 3 Look Cheap

Summary

While the market seems to have recovered, many big stocks are still near their 52-week lows, prompting a look into whether they are bargains or cheap for a reason. After analyzing valuation, growth, business quality, and balance sheet strength, Abbott Laboratories emerges as the top pick, offering the best balance of quality, valuation, and margin of safety. Visa is a close second, representing an elite company at a more reasonable price, followed by Salesforce and Uber for their significant resets and improving fundamentals.